RxSight
RXST
RXST
169 hedge funds and large institutions have $1.22B invested in RxSight in 2023 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 57 increasing their positions, 45 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11.99% more ownership
Funds ownership: 72.24% → 84.22% (+12%)
12% more call options, than puts
Call options by funds: $5.58M | Put options by funds: $4.99M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
169
Holding in Top 10
2
Calls
$5.58M
Puts
$4.99M
Top Buyers
| 1 | +$47.8M | |
| 2 | +$37.7M | |
| 3 | +$27.9M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$16.8M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$14.2M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$21M | |
| 3 | -$16.6M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$9.08M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$8.13M |